Core Scientific Inc (CORZ) concluded trading on Wednesday at a closing price of $3.80, with 3.47 million shares of worth about $13.2 million changed hands on the day. On Wednesday the price saw a gain of about 3.54%. Currently the company’s common shares owned by public are about 388.26M shares, out of which, 383.37M shares are available for trading.
Over the period of past 52 weeks, stock dropped to lowest price of $2.61 but also hit the highest price of $6.10 during that period. The average intraday trading volume for Core Scientific Inc shares is 2.83 million. The stock is currently trading 13.55% above its 20-day simple moving average (SMA20), while that difference is up 13.55% for SMA50 and it goes to 13.55% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock has a current market capitalization of $1.48B. It has posted earnings per share of -$1.32 in the same period. It has Quick Ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CORZ, volatility over the week remained 8.98%.
Analysts are in expectations that Core Scientific Inc (CORZ) stock would likely to be making an EPS of -$0.15 in the current quarter, while forecast for next quarter EPS is -$0.08 and it is -$0.25 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.17 which is -$0.13 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.41 in the same quarter a year ago.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Compass Point on January 31, 2024 offering a Buy rating for the stock and assigned a target price range of between $1 and $8.50 to it.
